Riskpilot← Back to searchSign inGet full accessHOFSETH BIOCARE RØRVIK AS
ASActiveOrg 997667468Marøya, 7900 RørvikManufacture of oils and fats · NACE 1041Est. 20110 employees
Revenue 2025
NOK 0
EBITDA margin
—
+37% vs 2024
Equity ratio
-116255.9%
Financial strength
Net profit 2025
NOK -2K
+37% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -2K | +37% |
| Net profit | NOK -2K | +37% |
| Total assets | NOK 1K | -64% |
| Equity | NOK -1,4M | +0% |
| Employees | 0 | — |
Legal name
HOFSETH BIOCARE RØRVIK AS
Org number
997667468
Legal form
Aksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
30. november 2011
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Foredling, utvikling og salg av olje-, protein- og kalsium-produkter fra avskjær fra fisk fra fiskeindustrien, samt service- og konsulenttjenester og deltakelse i andre selskaper som er relatert til dette.
Address
Marøya, 7900 Rørvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −3 | −3 | −4 | −4 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −3 | −4 | −4 | −2 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −3 | −3 | −4 | −4 | −2 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −3 | −4 | −4 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 | 0 | 7 | 3 | 1 |
| Equity | −1 408 | −1 411 | −1 415 | −1 418 | −1 421 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 411 | 1 411 | 1 422 | 1 422 | 1 422 |
| Total debt | 1 411 | 1 411 | 1 422 | 1 422 | 1 422 |
EBITDA margin
-220100.0%
This company
15.8%
Market median
-1393138% vs market
20212025
Equity ratio
-116255.9%
This company
38.2%
Market median
-304435% vs market
20212025
Return on equity
-220100.0%
This company
18.4%
Market median
-1196296% vs market
20212025
Net profit margin
-220100.0%
This company
8.1%
Market median
-2717384% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2022 | |
| Company | 49% | 49% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
3bh Invest As
HOFSETH BIOCARE RØRVIK AS Board members of HOFSETH BIOCARE RØRVIK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Wilhelm Sinkaberg | Board of Directors | 0 companies |
| Svein Gustav Sinkaberg | Board of Directors | 0 companies |
| Roger Hofseth | Board of Directors | 0 companies |
| Jon Olav Ødegård | Chairman | 0 companies |